These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 8477127)

  • 1. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin pharmacokinetics and dosing in premature neonates.
    McDougal A; Ling EW; Levine M
    Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
    Kildoo CW; Lin LM; Gabriel MH; Folli HL; Modanlou HD
    Dev Pharmacol Ther; 1989; 14(2):77-83. PubMed ID: 2630235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetic profile of vancomycin in neonates.
    Silva R; Reis E; Bispo MA; Almeida AM; Costa IM; Falcão F; Palminha JM; Falcão AC
    J Pharm Pharmacol; 1998 Nov; 50(11):1255-60. PubMed ID: 9877311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants.
    Lisby-Sutch SM; Nahata MC
    Eur J Clin Pharmacol; 1988; 35(6):637-42. PubMed ID: 3234472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of vancomycin in neonates.
    Seay RE; Brundage RC; Jensen PD; Schilling CG; Edgren BE
    Clin Pharmacol Ther; 1994 Aug; 56(2):169-75. PubMed ID: 8062493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
    He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of vancomycin in patients with severe acute pancreatitis and its influencing factors: analysis of 7 years data].
    He J; Mao E; Jing F; Jiang H; Yang W; Chen E
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):491-495. PubMed ID: 28625235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny.
    Kearns GL; Robinson PK; Wilson JT; Wilson-Costello D; Knight GR; Ward RM; van den Anker JN;
    Clin Pharmacol Ther; 2003 Oct; 74(4):312-25. PubMed ID: 14534518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.
    Pawlotsky F; Thomas A; Kergueris MF; Debillon T; Roze JC
    Br J Clin Pharmacol; 1998 Aug; 46(2):163-7. PubMed ID: 9723826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose regimen for vancomycin not needing serum peak levels?
    Tan WH; Brown N; Kelsall AW; McClure RJ
    Arch Dis Child Fetal Neonatal Ed; 2002 Nov; 87(3):F214-6. PubMed ID: 12390995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical pharmacology of vancomycin in seriously ill preterm infants.
    Reed MD; Kliegman RM; Weiner JS; Huang M; Yamashita TS; Blumer JL
    Pediatr Res; 1987 Sep; 22(3):360-3. PubMed ID: 3658557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.